NCT01479270

Brief Summary

The Transversus Abdominal Plane (TAP) block has been used with good success to decrease postoperative pain following laparatomy. If the TAP block provides any improvement in the quality of recovery following laparoscopic hysterectomy, it could decrease the need for postoperative narcotics and allow for more outpatient hysterectomy procedures.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2011

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2011

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2011

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 22, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 24, 2011

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2012

Completed
6.8 years until next milestone

Results Posted

Study results publicly available

October 11, 2018

Completed
Last Updated

October 11, 2018

Status Verified

October 1, 2018

Enrollment Period

4 months

First QC Date

November 22, 2011

Results QC Date

May 10, 2018

Last Update Submit

October 5, 2018

Conditions

Keywords

recoverypostoperativepainlaparoscopyhysterectomyropivacaineTAP blocklocal anesthesia

Outcome Measures

Primary Outcomes (1)

  • Quality of Recovery Questionnaire (QoR-40) on Postop Day #1 or #2

    40 question survey completed on paper or by telephone on post-operative day #1 or #2, designed to measure health status after surgery and anesthesia. Scale ranges from 40 (extremely poor qualify of recovery) to 200 (excellent quality of recovery).

    Postop Day #1 or Day #2

Secondary Outcomes (3)

  • Narcotic Use

    Postop Day #0 and Day #1

  • Visual Analog Scale (VAS) for Pain

    2 and 24 hours post operative

  • Intraoperative Time

    the total intraoperative time in minutes

Study Arms (2)

TAP Block

ACTIVE COMPARATOR

20mL of 0.25% Ropivacaine with Epinephrine 1:200,000 is injected into bilateral transversus abdominal planes under ultrasound guidance.

Drug: TAP Block

No Block

NO INTERVENTION

Patients randomized to this arm have band aids applied to sites on lateral abdomen without injection.

Interventions

Bilateral transversus abdominal plane injection under ultrasound guidance, done at conclusion of hysterectomy procedure, prior to emergence from general anesthesia

Also known as: Ropivacaine with Epinephrine
TAP Block

Eligibility Criteria

Age18 Years - 80 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Any patient undergoing laparoscopic hysterectomy
  • Age ranges 18-80
  • Reading literacy
  • English speaking
  • Able to give informed consent

You may not qualify if:

  • History of relevant drug allergy
  • Chronic opioid users who may have tolerance to pain medications
  • Inability to understand written consent forms or give consent
  • Age less than 18 or over 80
  • Any conversion to open surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Kane SM, Garcia-Tomas V, Alejandro-Rodriguez M, Astley B, Pollard RR. Randomized trial of transversus abdominis plane block at total laparoscopic hysterectomy: effect of regional analgesia on quality of recovery. Am J Obstet Gynecol. 2012 Nov;207(5):419.e1-5. doi: 10.1016/j.ajog.2012.06.052. Epub 2012 Jun 29.

MeSH Terms

Conditions

Pain, PostoperativePain

Interventions

RopivacaineEpinephrine

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesEthanolaminesAmino AlcoholsAlcoholsBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Results Point of Contact

Title
Robert Pollard
Organization
MetroHealth Medical Center

Study Officials

  • Sarah M Kane, MD

    MetroHealth Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Fellow, Principal Investigator

Study Record Dates

First Submitted

November 22, 2011

First Posted

November 24, 2011

Study Start

May 1, 2011

Primary Completion

September 1, 2011

Study Completion

January 1, 2012

Last Updated

October 11, 2018

Results First Posted

October 11, 2018

Record last verified: 2018-10